Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
300119.SZ Stock Price Chart
Explore Tianjin Ringpu Bio-Technology Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 300119.SZ price movements and trends.
300119.SZ Company Profile
Discover essential business fundamentals and corporate details for Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
17 Sept 2010
Employees
2.50K
Website
https://www.ringpu.comCEO
Lei Xu
Description
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sales of veterinary biological products, veterinary drug preparations, functional additives, and veterinary raw materials in China. The company provides vaccines and drugs for poultry, swine, and other animals; pet products comprising pet rabies inactivated vaccine, recombinant canine-a interferon, inhalation anesthetics isoflurane and sevoflurane for dogs and cats, cefquinoxime sulfate for injection for prevention and treatment of pet bacterial diseases, heart disease drugs for dogs and cats, napril chewable tablets and other products; and waterfowl products, including duck tempusu live/inactivated vaccine, gosling plague refined egg yolk antibody, duck infectious serositis inactivated vaccine, duck viral hepatitis refined egg yolk antibody, duck plague live vaccine, florfenicol soluble powder, kanamycin injection, etc. It also offers antifungal products, such as natural plant extracts, immune polysaccharides, clostridium butyricum, lactobacillus plantarum, antibacterial peptides, enzyme preparations, acidulants, etc; disinfection and cleaning products, consisting of potassium hydrogen persulfate composite powder, benzyl trimethyl ammonium chloride solution, deca methyl ammonium bromide solution, sodium dichloroisocyanurate, iodine glycerin solution, etc.; and APIs comprising tilmicosin, tilmicosin phosphate, monbutone, tidiroxine, florfenicol, vonimulin hydrochloride, gamimycin, etc. The company was founded in 1998 and is based in Tianjin, China.
300119.SZ Financial Timeline
Browse a chronological timeline of Tianjin Ringpu Bio-Technology Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 26 Aug 2025
EPS came in at ¥0.30 , while revenue for the quarter reached ¥886.00M .
Dividend declared on 21 May 2025
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 21 May 2025.
Earnings released on 26 Apr 2025
EPS came in at ¥0.12 , while revenue for the quarter reached ¥1.32B .
Earnings released on 2 Apr 2025
EPS came in at ¥0.25 , while revenue for the quarter reached ¥821.62M .
Earnings released on 29 Oct 2024
EPS came in at ¥0.18 , while revenue for the quarter reached ¥647.77M .
Earnings released on 23 Aug 2024
EPS came in at ¥0.16 , while revenue for the quarter reached ¥558.43M .
Dividend declared on 15 May 2024
A dividend of ¥0.40 per share was announced, adjusted to ¥0.40. The dividend was paid on 15 May 2024.
Earnings released on 25 Apr 2024
EPS came in at ¥0.19 , while revenue for the quarter reached ¥533.20M .
Earnings released on 29 Mar 2024
EPS came in at ¥0.39 surpassing the estimated ¥0.31 by +25.32%, while revenue for the quarter reached ¥661.80M , missing expectations by -2.95%.
Earnings released on 25 Oct 2023
EPS came in at ¥0.21 falling short of the estimated ¥0.28 by -25.00%, while revenue for the quarter reached ¥593.07M , missing expectations by -20.43%.
Earnings released on 25 Aug 2023
EPS came in at ¥0.21 matching the estimated ¥0.21, while revenue for the quarter reached ¥551.32M .
Dividend declared on 8 Jun 2023
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 8 Jun 2023.
Earnings released on 26 Apr 2023
EPS came in at ¥0.17 falling short of the estimated ¥0.23 by -26.09%, while revenue for the quarter reached ¥607.49M .
Earnings released on 1 Apr 2023
EPS came in at ¥0.25 falling short of the estimated ¥0.37 by -32.43%, while revenue for the quarter reached ¥442.78M , missing expectations by -27.19%.
Earnings released on 25 Oct 2022
EPS came in at ¥0.20 surpassing the estimated ¥0.18 by +11.11%, while revenue for the quarter reached ¥568.42M .
Earnings released on 25 Aug 2022
EPS came in at ¥0.15 falling short of the estimated ¥0.19 by -21.05%, while revenue for the quarter reached ¥517.53M .
Dividend declared on 13 Jun 2022
A dividend of ¥0.35 per share was announced, adjusted to ¥0.35. The dividend was paid on 13 Jun 2022.
Earnings released on 29 Apr 2022
EPS came in at ¥0.16 , while revenue for the quarter reached ¥390.81M , missing expectations by -40.95%.
Earnings released on 25 Mar 2022
EPS came in at ¥0.29 falling short of the estimated ¥0.42 by -30.95%, while revenue for the quarter reached ¥508.19M .
Earnings released on 26 Oct 2021
EPS came in at ¥0.22 , while revenue for the quarter reached ¥458.24M .
Earnings released on 27 Aug 2021
EPS came in at ¥0.22 , while revenue for the quarter reached ¥480.79M .
Earnings released on 29 Apr 2021
EPS came in at ¥0.29 , while revenue for the quarter reached ¥559.91M .
Dividend declared on 22 Apr 2021
A dividend of ¥0.40 per share was announced, adjusted to ¥0.40. The dividend was paid on 22 Apr 2021.
Earnings released on 1 Mar 2021
EPS came in at ¥0.37 , while revenue for the quarter reached ¥539.09M .
Earnings released on 29 Oct 2020
EPS came in at ¥0.26 , while revenue for the quarter reached ¥536.99M .
300119.SZ Stock Performance
Access detailed 300119.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.